(IBHG) iShares iBonds 2027 Term - Ratings and Ratios
High Yield Bonds, BBB-Rated Bonds
Dividends
| Dividend Yield | 6.33% |
| Yield on Cost 5y | 7.45% |
| Yield CAGR 5y | 27.92% |
| Payout Consistency | 97.7% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 1.75% |
| Value at Risk 5%th | 2.94% |
| Relative Tail Risk | 2.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.66 |
| Alpha | 0.53 |
| CAGR/Max DD | 1.69 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.347 |
| Beta | 0.145 |
| Beta Downside | 0.157 |
| Drawdowns 3y | |
|---|---|
| Max DD | 4.37% |
| Mean DD | 0.58% |
| Median DD | 0.22% |
Description: IBHG iShares iBonds 2027 Term December 31, 2025
The iShares iBonds 2027 Term High Yield and Income ETF (IBHG) tracks a U.S.-dollar, taxable, fixed-rate bond index that holds only high-yield and BBB-rated corporate issues maturing between 1 Jan 2027 and 15 Dec 2027. The fund must allocate at least 80 % of its assets to the index constituents and at least 90 % to the same fixed-income categories, ensuring tight alignment with the defined maturity window.
Key market drivers for IBHG include the high-yield spread over Treasuries (currently around 4.2 % p.a.), corporate default rates (≈2.5 % annualized in 2024 Q4), and the U.S. Federal Reserve’s policy stance, which directly influences the fund’s effective duration of roughly 5 years. A rising credit-supply environment in the leveraged-loan market can also affect pricing pressure on the underlying bonds.
For a deeper dive into IBHG’s risk-adjusted performance and how it fits within a diversified income strategy, you might explore the analytics on ValueRay.
What is the price of IBHG shares?
Over the past week, the price has changed by +0.07%, over one month by +0.47%, over three months by +1.10% and over the past year by +6.21%.
Is IBHG a buy, sell or hold?
What are the forecasts/targets for the IBHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25.4 | 13.6% |
IBHG Fundamental Data Overview January 14, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 451.9m USD (451.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 451.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 451.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.45% (E(451.9m)/V(451.9m) * Re(6.45%) + (debt-free company))
Discount Rate = 6.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBHG ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle